Indivior Pharmaceuticals Quarterly Balance Sheet
NASDAQ: INDVHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Indivior Pharmaceuticals financial position
As of Jun 30, 2026, Indivior Pharmaceuticals reported total assets of $1.23 billion, down 15.1% from a year earlier against total liabilities of $1.44 billion. Shareholders' equity was negative at -$208.0 million, meaning liabilities exceed assets; this is often the result of large share buybacks or accumulated losses. The company held $222.0 million in cash and equivalents against $487.0 million of debt, a net debt position of $265.0 million.
The current ratio (current assets divided by current liabilities) was 0.84, meaning short-term obligations exceed short-term assets.
Summary generated from market data by MetaCap's automated system. Methodology
Indivior Pharmaceuticals balance sheet (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q4 20222022-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 222.00M | 175.00M | 195.00M | 445.00M | 510.00M | 372.00M | 319.00M | 288.00M | 302.00M | 248.00M | 316.00M | 774.00M |
| Short-Term Investments | — | — | 0 | 0 | 0 | 1.00M | 1.00M | — | — | — | 94.00M | — |
| Receivables | 271.00M | 273.00M | 253.00M | 259.00M | 240.00M | 243.00M | 254.00M | — | — | — | 254.00M | — |
| Inventory | 150.00M | 152.00M | 153.00M | 155.00M | 149.00M | 163.00M | 167.00M | — | — | — | 126.00M | 114.00M |
| Total Current Assets | 725.00M | 667.00M | 652.00M | 922.00M | 951.00M | 883.00M | 827.00M | — | — | — | 1.26B | 1.26B |
| Property, Plant & Equipment | 162.00M | 157.00M | 144.00M | 124.00M | 117.00M | 104.00M | 100.00M | — | — | — | 84.00M | 54.00M |
| Goodwill | — | — | 2.00M | — | — | — | 2.00M | — | — | — | 5.00M | — |
| Long-Term Investments | 27.00M | 27.00M | 28.00M | 28.00M | 27.00M | 27.00M | 27.00M | — | — | — | 41.00M | — |
| Total Assets | 1.23B | 1.20B | 1.20B | 1.42B | 1.45B | 1.38B | 1.32B | — | — | — | 1.76B | 1.77B |
| Accounts Payable | 30.00M | 35.00M | 48.00M | 41.00M | 50.00M | 46.00M | 63.00M | — | — | — | 39.00M | 617.00M |
| Short-Term Debt | 0 | 0 | 29.00M | 18.00M | 18.00M | 18.00M | 18.00M | — | — | — | 6.00M | 3.00M |
| Total Current Liabilities | 868.00M | 779.00M | 914.00M | 965.00M | 1.06B | 1.00B | 924.00M | — | — | — | 1.28B | 1.02B |
| Long-Term Debt | 487.00M | 486.00M | 290.00M | 304.00M | 308.00M | 311.00M | 315.00M | — | — | — | 237.00M | 237.00M |
| Total Liabilities | 1.44B | 1.34B | 1.30B | 1.62B | 1.71B | 1.66B | 1.65B | — | — | — | 1.94B | 1.72B |
| Shareholders' Equity | -208.00M | -144.00M | -98.00M | -207.00M | -257.00M | -285.00M | -337.00M | -310.00M | -281.00M | -161.00M | -184.00M | -15.00M |
| Retained Earnings | -334.00M | -280.00M | -243.00M | -346.00M | -388.00M | -406.00M | -443.00M | — | — | — | -288.00M | 1.30B |
| Total Debt | 487.00M | 486.00M | 319.00M | 322.00M | 326.00M | 329.00M | 333.00M | — | — | — | 243.00M | 240.00M |
| Net Cash (Debt) | -265.00M | -311.00M | -124.00M | 123.00M | 184.00M | 44.00M | -13.00M | 288.00M | 302.00M | 248.00M | 167.00M | 534.00M |
This table shows 12 quarterly periods of Indivior Pharmaceuticals's balance sheet, from Q2 2026 back to Q4 2022, across 18 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow INDV's reporting calendar. What is a balance sheet?